These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 39149094)
1. Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, Singh G; Singh R; Monga V; Mehan S RSC Med Chem; 2024 Aug; 15(8):2826-2854. PubMed ID: 39149094 [TBL] [Abstract][Full Text] [Related]
2. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation. Singh G; Singh R; Monga V; Mehan S Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989 [TBL] [Abstract][Full Text] [Related]
3. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents. Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives. Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship, Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives. Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing Khan I; Rehman W; Rahim F; Hussain R; Khan S; Rasheed L; Alanazi MM; Alanazi AS; Abdellattif MH ACS Omega; 2023 Jun; 8(25):22508-22522. PubMed ID: 37396210 [TBL] [Abstract][Full Text] [Related]
8. Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, Ghannay S; Aldhafeeri BS; Ahmad I; E A E Albadri A; Patel H; Kadri A; Aouadi K Heliyon; 2024 Feb; 10(4):e25911. PubMed ID: 38380049 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of modified Schiff base appended 1,2,4-triazole hybrids scaffolds: elucidating the Abbasi SA; Rahim F; Hussain R; Rehman W; Khan S; Taha M; Iqbal T; Khan Y; Ali Shah SA Z Naturforsch C J Biosci; 2024 Jul; ():. PubMed ID: 38996406 [TBL] [Abstract][Full Text] [Related]
10. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations. Zahra S; Zaib S; Khan I Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537 [TBL] [Abstract][Full Text] [Related]
11. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches. Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, ADMT prediction, and Safapoor S; Halimi M; Ghomi MK; Noori M; Dastyafteh N; Javanshir S; Hosseini S; Mojtabavi S; Faramarzi MA; Nasli-Esfahani E; Larijani B; Fakhrioliaei A; Dekamin MG; Mohammadi-Khanaposhtani M; Mahdavi M RSC Adv; 2023 Jun; 13(28):19243-19256. PubMed ID: 37377867 [TBL] [Abstract][Full Text] [Related]
13. Molecular hybridization, synthesis, in vitro α-glucosidase inhibition, in vivo antidiabetic activity and computational studies of isatin based compounds. Patil S; Alegaon SG; Gharge S; Ranade SD; Khatib NA Bioorg Chem; 2024 Sep; 153():107783. PubMed ID: 39255610 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and enzymatic inhibition evaluation of novel 4-hydroxy Pd-C-Ⅲ derivatives as α-glucosidase and PTP1B dual-target inhibitors. Yang W; Chen J; Peng Z; Wang G Eur J Med Chem; 2024 Dec; 280():116938. PubMed ID: 39378828 [TBL] [Abstract][Full Text] [Related]
15. Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, Srinivasa MG; Paithankar JG; Saheb Birangal SR; Pai A; Pai V; Deshpande SN; Revanasiddappa BC RSC Adv; 2023 Jan; 13(3):1567-1579. PubMed ID: 36712616 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as α-glucosidase inhibitors with antidiabetic activity. Hu C; Liang B; Sun J; Li J; Xiong Z; Wang SH; Xuetao X Eur J Med Chem; 2024 Jan; 264():115957. PubMed ID: 38029465 [TBL] [Abstract][Full Text] [Related]
17. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation. Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516 [TBL] [Abstract][Full Text] [Related]
18. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies. Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965 [TBL] [Abstract][Full Text] [Related]